GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from three phase III studies. Two studies comparin... BiopharmaceuticalsGlaxoSmithKline, Theravance, Anoro Ellipta, Advair Diskus, COPD
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news